Schilke Tobin
Insider CIK 1678984 · AKAO Chief Financial Officer · RVNC Chief Financial Officer · CRNX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 50,000 | $41.21 | $2.06M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 80,000 | $51.25 | $4.10M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 7,956 | $85.00 | $676.3K | 71,471 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 71,471 | $85.00 | $6.08M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 50,000 | $41.21 | $2.06M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 80,000 | $51.25 | $4.10M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 71,471 | $85.00 | $6.08M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 7,956 | $85.00 | $676.3K | 71,471 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-08-20 | 2026-08-24 | 471 | — | $0 | 79,427 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-08-20 | 2026-08-24 | 471 | — | $0 | 79,427 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-03-03 | 2026-03-04 | 6,713 | $39.67 | $266.3K | 78,121 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2026-02-23 | 2026-02-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-02-23 | 2026-02-25 | 32,000 | — | $0 | 84,834 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2025-03-10 | 2025-03-11 | 80,000 | — | $0 | 80,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2025-03-10 | 2025-03-11 | 52,000 | — | $0 | 52,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2025-02-06 | 2025-02-06 | 20,883 | — | $0 | 20,883 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | D To issuer | 2025-02-06 | 2025-02-06 | 103,555 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | D To issuer | 2025-02-06 | 2025-02-06 | 20,883 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | U Tender | 2025-02-04 | 2025-02-06 | 97,999 | $3.65 | $357.7K | 103,555 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2025-02-03 | 2025-02-05 | 6,888 | — | $0 | 201,554 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-12-31 | 2025-01-03 | 1,000 | $2.18 | $2.2K | 194,666 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-06-30 | 2024-07-02 | 1,000 | $2.18 | $2.2K | 193,666 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2024-03-18 | 2024-03-19 | 9,361 | $5.04 | $47.2K | 192,666 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2024-03-15 | 2024-03-19 | 3,822 | $5.31 | $20.3K | 202,027 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-02-29 | 2024-03-04 | 17,447 | — | $0 | 205,849 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 145,001 | — | $0 | 145,001 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 96,667 | — | $0 | 188,402 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-12-31 | 2024-01-03 | 434 | $7.47 | $3.2K | 91,735 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-08-11 | 2023-08-15 | 22,620 | — | $0 | 102,516 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2023-08-11 | 2023-08-15 | 11,215 | $18.91 | $212.1K | 91,301 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-07-03 | 2023-07-05 | 1,701 | $25.04 | $42.6K | 79,896 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-06-30 | 2023-07-05 | 769 | $15.61 | $12.0K | 81,597 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-06-02 | 2023-06-05 | 500 | $31.00 | $15.5K | 80,828 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-06-01 | 2023-06-05 | 2,701 | $30.57 | $82.6K | 81,328 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-05-15 | 2023-05-16 | 21,401 | $34.55 | $739.4K | 84,029 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-05-01 | 2023-05-02 | 3,201 | $31.70 | $101.5K | 63,081 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-04-03 | 2023-04-04 | 3,201 | $32.15 | $102.9K | 66,282 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2023-03-15 | 2023-03-17 | 3,739 | $30.65 | $114.6K | 69,483 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-03-09 | 2023-03-09 | 18,517 | $31.59 | $585.0K | 73,222 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-02 | 3,201 | $33.50 | $107.2K | 49,390 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2023-02-15 | 2023-02-16 | 2,085 | $33.21 | $69.2K | 52,591 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-02 | 3,201 | $34.60 | $110.8K | 54,676 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 50,435 | — | $0 | 50,435 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-01-20 | 2023-01-23 | 1,000 | $31.00 | $31.0K | 57,877 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-01-09 | 2023-01-10 | 1,000 | $30.00 | $30.0K | 58,877 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-01-09 | 2023-01-10 | 1,000 | $28.00 | $28.0K | 59,877 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-01-09 | 2023-01-10 | 1,701 | $25.00 | $42.5K | 60,877 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-12-31 | 2023-01-03 | 645 | $12.18 | $7.9K | 62,578 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-12-15 | 2022-12-16 | 1,557 | $21.50 | $33.5K | 61,933 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-09-22 | 2023-03-09 | 42,349 | — | $0 | 91,739 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-06-30 | 2022-07-05 | 965 | $11.75 | $11.3K | 63,490 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-03-15 | 2022-03-17 | 2,607 | $15.79 | $41.2K | 62,525 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-02-15 | 2022-02-17 | 683 | $13.35 | $9.1K | 65,132 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-02-15 | 2022-02-17 | 2,241 | $13.35 | $29.9K | 65,815 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-02-02 | 2023-05-16 | 42,349 | — | $0 | 105,430 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-02-02 | 2022-02-04 | 68,093 | — | $0 | 68,093 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2021-12-31 | 2022-01-04 | 404 | $13.87 | $5.6K | 68,056 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2021-12-15 | 2021-12-17 | 1,556 | $15.92 | $24.8K | 67,652 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2021-06-30 | 2021-07-02 | 446 | $24.09 | $10.7K | 69,208 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2021-02-15 | 2021-02-19 | 684 | $28.97 | $19.8K | 70,735 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2021-02-15 | 2021-02-19 | 1,973 | $28.97 | $57.2K | 68,762 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2021-02-02 | 2021-02-04 | 40,925 | — | $0 | 40,925 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-02-02 | 2021-02-04 | 22,620 | — | $0 | 71,419 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2020-12-31 | 2021-01-04 | 493 | $21.36 | $10.5K | 48,799 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2020-12-15 | 2020-12-22 | 1,556 | $26.75 | $41.6K | 48,306 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-09-30 | 2020-10-02 | 15,750 | — | $0 | 55,308 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2020-09-30 | 2020-10-02 | 5,446 | $25.14 | $136.9K | 49,862 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2020-06-30 | 2020-07-02 | 763 | $13.80 | $10.5K | 39,558 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2020-02-15 | 2020-02-19 | 576 | $25.33 | $14.6K | 38,795 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2020-01-23 | 2020-01-24 | 97,500 | $22.32 | $2.18M | 97,500 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-01-23 | 2020-01-24 | 16,500 | — | $0 | 39,371 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2019-12-31 | 2020-01-03 | 504 | $10.82 | $5.5K | 22,871 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2019-12-15 | 2019-12-17 | 1,556 | $15.99 | $24.9K | 22,367 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2019-06-28 | 2019-07-02 | 923 | $11.02 | $10.2K | 23,923 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2019-01-24 | 2019-01-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2019-01-24 | 2019-01-25 | 5,000 | — | $0 | 23,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2018-11-05 | 2018-11-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2018-11-05 | 2018-11-07 | 18,000 | — | $0 | 18,000 | SEC↗ |
| AKAO Achaogen Inc | A Award deriv | 2018-06-26 | 2018-06-28 | 4,000 | — | $0 | 4,000 | SEC↗ |
| AKAO Achaogen Inc | S Sale | 2018-06-26 | 2018-06-28 | 298 | $9.59 | $2.9K | 47,748 | SEC↗ |
| AKAO Achaogen Inc | A Award | 2018-06-26 | 2018-06-28 | 860 | — | $0 | 48,046 | SEC↗ |
| AKAO Achaogen Inc | S Sale | 2018-06-11 | 2018-06-13 | 2,087 | $11.95 | $24.9K | 47,186 | SEC↗ |
| AKAO Achaogen Inc | S Sale | 2018-02-21 | 2018-02-23 | 1,108 | $10.67 | $11.8K | 40,185 | SEC↗ |
| AKAO Achaogen Inc | A Award deriv | 2018-02-08 | 2018-05-15 | 32,000 | — | $0 | 32,000 | SEC↗ |
| AKAO Achaogen Inc | A Award | 2018-02-08 | 2018-05-15 | 6,880 | — | $0 | 47,065 | SEC↗ |
| AKAO Achaogen Inc | S Sale | 2017-06-12 | 2017-06-14 | 2,066 | $21.53 | $44.5K | 40,119 | SEC↗ |
| AKAO Achaogen Inc | A Award deriv | 2017-02-22 | 2017-02-24 | 12,600 | — | $0 | 12,600 | SEC↗ |
| AKAO Achaogen Inc | A Award deriv | 2017-02-22 | 2017-02-24 | 50,400 | — | $0 | 50,400 | SEC↗ |
| AKAO Achaogen Inc | A Award | 2017-02-22 | 2017-02-24 | 13,500 | — | $0 | 39,545 | SEC↗ |
| AKAO Achaogen Inc | S Sale | 2017-01-26 | 2017-01-30 | 955 | $16.78 | $16.0K | 26,045 | SEC↗ |
| AKAO Achaogen Inc | A Award deriv | 2016-07-05 | 2016-07-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AKAO Achaogen Inc | A Award deriv | 2016-07-05 | 2016-07-06 | 26,000 | — | $0 | 26,000 | SEC↗ |
| AKAO Achaogen Inc | A Award | 2016-07-05 | 2016-07-06 | 27,000 | — | $0 | 27,000 | SEC↗ |